Shares of ResMed (NYSE: RMD) had soared 16.2% higher as of 11:50 a.m. ET on Friday. The big jump came after the healthcare technology company reported results on Thursday evening for its fiscal 2024 third quarter, which ended March 31.For the quarter, ResMed reported revenue of $1.2 billion, up 7% year over year, and earnings per share of $2.04, based on generally accepted accounting principles.
Open FlipJp Morgan CEO Jamie Dimon says stagflation could be one of a number of possible outcomes for the U.S. economy as the Federal Reserve attempts to tame stubbornly high consumer prices.In an interview with The Associated Press at a Chase branch opening in The Bronx, Dimon said he remained “cautious” about the U.S. economy and said inflation may be stickier for longer.
Open FlipExxonMobil is nowhere close to holding the kind of market power its Standard Oil ancestor enjoyed back in the day, but it certainly is cementing its lead over supermajor peers.On Friday, Exxon reported that first-quarter earnings were down 28% compared with a year earlier, driven by lower natural gas prices and refining margins. Earnings were 6.4% lower than what analysts polled by Visible Alpha.
Open Flip